Das ehemalige Krankenhaus Maria Hilf steht in Mönchengladbach, Sandradstraße 43–47. Die hier bis Mitte 2018 beheimateten Fachkliniken wurden im Rahmen der Standortzusammenlegung zu Ende des 5. Bauabschnittes im Krankenhaus St. Franziskus in die dort neuen Gebäude an der Viersener Str. 450 verlegt.

During the past decade, Kliniken Maria Hilf GmbH conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 18 clinical trials were completed, i.e. on average, 43.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 13 clinical trials were completed. i.e. 81.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kliniken Maria Hilf GmbH" #1 sponsor was "German CLL Study Group" with 7 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored, "Bayer" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Ipsen" with 3 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kliniken Maria Hilf GmbH" #1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Nordic CLL Study Group (NCLLSG)" with 2 trials as a collaborator and "Trium Analysis Online GmbH" with 2 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Kliniken Maria Hilf GmbH" are "Atrial Fibrillation" (6 trials), "Lymphoma" (6 trials), "Chronic Lymphocytic Leukemia" (5 trials), "Colorectal Cancer" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Kliniken Maria Hilf GmbH" in a lesser frequency.

Most popular intervention types in "Kliniken Maria Hilf GmbH" are "Drug" (48 trials), "Biological" (16 trials), "Radiation" (9 trials), "Other" (7 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (7 trials), "cyclophosphamide" (7 trials), "Placebo" (6 trials), "radiation therapy" (6 trials) and "Obinutuzumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Kliniken Maria Hilf GmbH" are 69 trials for "All" genders.

Currently, there are NaN active trials in "Kliniken Maria Hilf GmbH". undefined are not yet recruiting, 11 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Kliniken Maria Hilf GmbH, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Kliniken Maria Hilf GmbH, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

Kliniken Maria Hilf GmbH has several departments that took part in Clinical trials: "Kliniken Maria Hilf GmbH Klinik für Hämatologie, Onkologie und Gastroenterologie" - 2 trials